Neurogenic Molecules Modulating Cell Survival Pathways, Amyloid Beta, Tau Proteins, and Metal Dyshomeostasis: An Alternative Hope for Alzheimer’s Therapy
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
243-264
Author(s):
Hailin Zheng, Mati Fridkin and Moussa B.H. Youdim
Alzheimer’s Disease and Dementia: A Midlife Approach to Treatment is Needed
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
217-242
Author(s):
Angela Clifford, Jennifer Stock, Stephan Bandelow, Tri Budi Rahardjo and Eef Hogervorst
Different Approaches in the Treatment of Alzheimer's Disease: Comprehensive Insight
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
183-216
Author(s):
Zaciragic Asija
Tau-Directed Therapies for Alzheimer’s Disease and Other Tauopathies
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
147-182
Author(s):
Yasumasa Yoshiyama
Next Generation Drugs in Alzheimer's Disease Treatment: From Benchtop to Bedside
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
109-146
Author(s):
Rosaria A. Cavallaro and Andrea Fuso
The Development of Multi-Target-Directed Ligands (MTDL) to Treat Alzheimer’s Disease
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
86-108
Author(s):
John W. Wright and Joseph W. Harding
Immunotherapy with Anti-Aβ Monoclonal Antibodies in Alzheimer’s Disease: A Critical Review on the Molecules in the Pipelines with Regulatory Considerations
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
3-85
Author(s):
Chrystelle Mavoungou and Katharina Schindowski Zimmerman
List of Contributors
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
iii-vi
Author(s):
Atta-ur-Rahman
Preface
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
i-ii
Author(s):
Atta-ur-Rahman
Index
Book:
Frontiers in CNS Drug Discovery
Page:
407-423
Author(s):
Atta-ur-Rahman and M. Iqbal Choudhary